Unknown PHASE4 INTERVENTIONAL 2-arm NCT01340339

Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants

Efficacy of Reverse Phototherapy With Super Light-emitting Diode(Super-led) in Term and Late Preterm Infants:Randomized and Controlled Clinical Trial

Sponsor: Professor Fernando Figueira Integral Medicine Institute

Conditions Neonatal Hyperbilirubinemia

Interventions Phototherapy

Updated 5 times since 2017 Last updated: Apr 21, 2011 Started: Oct 31, 2010 Primary completion: Oct 31, 2011 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01340339, this PHASE4 trial focuses on Neonatal Hyperbilirubinemia and remains ongoing. Sponsored by Professor Fernando Figueira Integral Medicine Institute, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Professor Fernando Figueira Integral Medicine Institute

Data source: Professor Fernando Figueira Integral Medicine Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Recife, Brazil